Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Newline Pharma is a specialty pharmaceutical company based in Barcelona, Spain, focused on the commercialization of innovative healthcare solutions. The company primarily operates in the ophthalmology, respiratory, and pain management sectors, offering a diverse portfolio of medical devices and pharmaceutical products. Newline Pharma serves as a strategic commercial partner for international laboratories, facilitating their entry into the Spanish and Portuguese markets. Their product line includes well-known brands such as Naviblef and Lacrifresh, which address common conditions like blepharitis and dry eye syndrome. By focusing on value-added medicines, the company aims to improve patient adherence and clinical outcomes through optimized delivery and formulations. Newline Pharma maintains a lean, agile structure that allows for rapid market penetration and specialized medical detailing.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Newline Pharma.